These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31664065)

  • 1. Relations of non-motor symptoms and dopamine transporter binding in REM sleep behavior disorder.
    Dušek P; Ibarburu VLYL; Bezdicek O; Dall'antonia I; Dostálová S; Kovalská P; Krupička R; Nepožitek J; Nikolai T; Novotný M; Peřinová P; Rusz J; Serranová T; Tykalová T; Ulmanová O; Mecková Z; Ptáčník V; Trnka J; Zogala D; Růžička E; Šonka K
    Sci Rep; 2019 Oct; 9(1):15463. PubMed ID: 31664065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
    Liu R; Umbach DM; Tröster AI; Huang X; Chen H
    Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.
    Pagano G; Yousaf T; Wilson H; Niccolini F; Polychronis S; Chaudhuri KR; Politis M
    Eur J Neurol; 2018 Feb; 25(2):307-312. PubMed ID: 29078029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with REM sleep behavior disorder have higher serum levels of allantoin.
    Hasíková L; Závada J; Serranová T; Kotačková L; Kozlík P; Kalíková K; Trnka J; Zogala D; Šonka K; Růžička E; Dušek P
    Parkinsonism Relat Disord; 2021 Sep; 90():38-43. PubMed ID: 34352609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
    J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls.
    Eisensehr I; Linke R; Tatsch K; Kharraz B; Gildehaus JF; Wetter CT; Trenkwalder C; Schwarz J; Noachtar S
    Sleep; 2003 Aug; 26(5):507-12. PubMed ID: 12938802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
    Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain cholinergic alterations in idiopathic REM sleep behaviour disorder: a PET imaging study with
    Bedard MA; Aghourian M; Legault-Denis C; Postuma RB; Soucy JP; Gagnon JF; Pelletier A; Montplaisir J
    Sleep Med; 2019 Jun; 58():35-41. PubMed ID: 31078078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.
    Noyce AJ; Dickson J; Rees RN; Bestwick JP; Isaias IU; Politis M; Giovannoni G; Warner TT; Lees AJ; Schrag A
    Mov Disord; 2018 Mar; 33(3):478-482. PubMed ID: 29380907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
    Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
    Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic biomarkers in prodromal α-synucleinopathies: DAT binding and REM sleep without atonia.
    Kunz D; Stotz S; de Zeeuw J; Papakonstantinou A; Dümchen S; Haberecht M; Plotkin M; Bes F
    J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):532-540. PubMed ID: 36725328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
    Arnaldi D; Chincarini A; Hu MT; Sonka K; Boeve B; Miyamoto T; Puligheddu M; De Cock VC; Terzaghi M; Plazzi G; Tachibana N; Morbelli S; Rolinski M; Dusek P; Lowe V; Miyamoto M; Figorilli M; Verbizier D; Bossert I; Antelmi E; Meli R; Barber TR; Trnka J; Miyagawa T; Serra A; Pizza F; Bauckneht M; Bradley KM; Zogala D; McGowan DR; Jordan L; Manni R; Nobili F
    Brain; 2021 Feb; 144(1):278-287. PubMed ID: 33348363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodromal Parkinsonism and Neurodegenerative Risk Stratification in REM Sleep Behavior Disorder.
    Barber TR; Lawton M; Rolinski M; Evetts S; Baig F; Ruffmann C; Gornall A; Klein JC; Lo C; Dennis G; Bandmann O; Quinnell T; Zaiwalla Z; Ben-Shlomo Y; Hu MTM
    Sleep; 2017 Aug; 40(8):. PubMed ID: 28472425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.